ENTITY

Incyte Corp (INCY US)

67
Analysis
Health CareUnited States
Incyte Corp is a biopharmaceutical company. The Company discovers, develops and commercializes proprietary small molecule drugs, primarily used in oncology.
more
22 Aug 2021 09:00

China Healthcare Weekly (Aug.20)

The article analyzed the logic change due to the centralized procurement on chemiluminescence products, new regulation about long-term...

Logo
240 Views
Share
bullishS&P 500 INDEX
22 Jul 2020 21:34

U.S. Equity Strategy: Bullish Outlook Intact

With the S&P 500 breaking above the June highs and the Russell 2000 bullishly inflecting topside a ~1-month base, it signals a continuation of...

Logo
392 Views
Share
bullishS&P 500 INDEX
28 Nov 2019 06:30

U.S. Equity Strategy: Upgrading Health Care to Overweight

Ongoing bullish developments continue to support our belief that we are in the early stages of a broad-based advance following a nearly 2-year...

Logo
380 Views
Share
bullishS&P 500 INDEX
06 Nov 2019 05:30

U.S. Equity Strategy: Small-Caps Testing Critical Resistance; Downgrading Communications

As bullish developments pile up, the weight-of-the-evidence continues to support our belief that we may be in the early stages of a broad-based...

Logo
412 Views
Share
bearishS&P 500 INDEX
09 Jan 2019 03:12

U.S. Equity Strategy: Oversold Rally Continues

A combination of, optimism surrounding U.S.-China trade talks, and Fed Chairman Powell’s comments have led to a continuation of the oversold bounce...

Logo
583 Views
Share
x